Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ajanta Pharma Ajanta Pharma Ltd. | BSE 2511.60 -4.50 (-0.18%) | NSE 2513.40 -4.30 (-0.17%) | Trade | Add

BSE Live

Nov 20, 12:36

2511.60 -4.50 (-0.18%)

Volume

AVERAGE VOLUME

5-Day

23,241

10-Day

13,196

30-Day

6,576

589

Prev. Close

2516.10
Open Price

2500.45

Bid Price (Qty.)
2511.05 (13)
Offer Price (Qty.)
2513.40 (1)

NSE Live

Nov 20, 12:36

2513.40 -4.30 (-0.17%)

Volume

AVERAGE VOLUME

5-Day

101,847

10-Day

89,125

30-Day

111,560

10,906

Prev. Close

2517.70
Open Price

2510.00

Bid Price (Qty.)
2512.10 (8)
Offer Price (Qty.)
2513.40 (17)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ajanta Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	17.54	17.54	17.69	17.69	17.69
Total Share Capital	17.54	17.54	17.69	17.69	17.69
Reserves and Surplus	2,580.86	2,226.57	2,023.68	1,550.00	1,173.17
Total Reserves and Surplus	2,580.86	2,226.57	2,023.68	1,550.00	1,173.17
Total Shareholders Funds	2,598.87	2,245.21	2,041.37	1,567.69	1,190.86
Minority Interest	0.00	0.00	0.00	0.00	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	0.74	0.66	1.01	1.04	14.87
Deferred Tax Liabilities [Net]	81.16	58.90	47.00	27.34	19.29
Other Long Term Liabilities	16.10	0.33	0.00	1.82	0.46
Long Term Provisions	15.65	13.44	13.16	3.15	2.59
Total Non-Current Liabilities	113.65	73.33	61.17	33.35	37.21
CURRENT LIABILITIES
Short Term Borrowings	42.85	33.34	0.00	0.00	46.25
Trade Payables	362.34	225.18	249.63	178.18	145.57
Other Current Liabilities	191.82	94.16	67.67	54.37	56.72
Short Term Provisions	9.16	24.96	28.75	14.11	11.35
Total Current Liabilities	606.17	377.64	346.05	246.66	259.89
Total Capital And Liabilities	3,318.69	2,696.18	2,448.59	1,847.70	1,487.96
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,460.43	1,171.90	1,045.21	583.16	446.98
Intangible Assets	11.71	6.65	7.45	6.01	3.76
Capital Work-In-Progress	131.86	261.29	61.33	338.03	238.42
Fixed Assets	1,604.00	1,439.84	1,113.99	928.43	690.54
Non-Current Investments	12.28	12.99	7.58	0.00	0.00
Deferred Tax Assets [Net]	25.40	31.81	22.61	24.45	8.58
Long Term Loans And Advances	6.52	0.00	0.00	0.00	0.00
Other Non-Current Assets	28.78	30.31	80.79	44.22	25.57
Total Non-Current Assets	1,676.98	1,514.95	1,224.97	997.10	724.69
CURRENT ASSETS
Current Investments	67.14	64.74	182.38	181.56	76.78
Inventories	495.68	435.71	350.63	211.02	204.58
Trade Receivables	775.30	459.48	492.02	323.15	372.35
Cash And Cash Equivalents	205.25	100.51	93.09	69.95	43.37
Short Term Loans And Advances	9.01	0.00	0.00	0.00	0.00
OtherCurrentAssets	89.33	120.79	105.50	64.92	66.19
Total Current Assets	1,641.71	1,181.23	1,223.62	850.60	763.27
Total Assets	3,318.69	2,696.18	2,448.59	1,847.70	1,487.96
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	182.41	306.30	173.56	146.11	123.92
BONUS DETAILS
Bonus Equity Share Capital	7.09	7.09	7.09	7.09	7.09
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	12.28	12.99	7.58	0.00	0.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	15.34	36.97	0.00	0.00	76.78
Current Investments Unquoted Book Value	51.80	27.77	182.38	181.56	0.00